Suppression of the kinase activity of receptor tyrosine kinases by anthocyanin-rich mixtures extracted from bilberries and grapes

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 8, 2009, Pages 3094-3101

  Teller, Nicole ^a,b,c,d   Thiele, Wilko ^a,b,c,d   Marczylo, Timothy H ^a,b,c,d   Gescher, Andreas J ^a,b,c,d   Boettler, Ute ^a,b,c,d   Sleeman, Jonathan ^a,b,c,d   Marko, Doris ^a,b,c,d  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Chemoprevention; ErbB receptor family; Polyphenol; VEGFR

Indexed keywords

ANTHOCYANIN; PLANT EXTRACT; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ANIMAL; AORTA; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FRUIT; GRAPE; HUMAN; PHOSPHORYLATION; SWINE; TUMOR CELL LINE; VACCINIUM MYRTILLUS; VULVA TUMOR;

ANIMALS; ANTHOCYANINS; AORTA; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; FRUIT; HUMANS; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN KINASE INHIBITORS; RECEPTOR PROTEIN-TYROSINE KINASES; SWINE; VACCINIUM MYRTILLUS; VITIS; VULVAR NEOPLASMS;

SUS; VITACEAE;

EID: 65349095233     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803094a     Document Type: Article

References (39)

1. Cooke, D.; Schwarz, M.; Boocock, D.; Winterhalter, P.; Steward, W. P.; Gescher, A. J.; Marczylo, T. H. Effect of cyanidin-3-glycoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcino-genesis: Relationship with tissue anthocyanin levels. Int. J. Cancer 2006, 119, 2213-2220.
2. Wu, X.; Beecher, G. R.; Holden, J. M.; Haytowitz, D. B.; Gebhardt, S. E.; Prior, R. L. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem. 2006, 54, 4069-4075.
3. Meiers, S.; Kemény, M.; Weyand, U.; Gastpar, R.; von Angerer, E.; Marko, D. The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. J. Agric. Food Chem. 2001, 49, 958-962.
4. Mazza, G Anthocyanins in grapes and grape products. Crit Rev Food Sci Nutr. 1995, 35, 341-371.
5. Zafra-Stone, S.; Yasmin, T.; Bagchi, M.; Chatterjee, A.; Vinson, J. A.; Bagchi, D. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res. 2007, 51, 675-683.
6. Lamy, S.; Blanchette, M.; Michaud-Levesque, J.; Lafleur, R.; Durocher, Y.; Moghrabi, A.; Barrette, S.; Gingras, D.; Béliveau, R. Delphinidin, a dietary anthocyanidin, inhibits vascular endot-helial growth factor receptor-2 phosphorylation. Carcinogenesis 2006, 27, 989-996.
7. Yi, W.; Fischer, J.; Krewer, G.; Akoh, C. C. Phenolic compounds from Blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J. Agric. Food Chem. 2005, 53, 7320-7329.
8. Yarden, Y.; Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
9. Olayioye, M. A.; Neve, R. M.; Lane, A. H.; Hynes, N. E. The ErbB signalling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19, 3159-3167.
10. Hynes, N. E.; Lane, H. A. ErbB receptors and cancer: The complexity of Target inhibitors. Nat. Rev. Cancer 2005, 5, 341- 354.
11. Holboro, T.; Civenni, C.; Hynes, N. E. The ErbB receptors and their role in cancer progression. EXP. Cell Res. 2003, 284, 99-110.
12. Karamouzis, M. V.; Badra, F. A.; Papavassiliou, A. G Breast cancer: The upgraded role of Her-3 and Her-4. IJBCB 2007, 39, 851-856.
13. Mitsiades, C. S.; Mitsiades, N. S.; McMullan, C. J.; Poulaki, V.; Shringarpure, R.; Akiyama, M.; Hideshima, T.; Chauhan, D.; Joseph, M.; Libermann, T. A.; Garcia-Echeverría, C.; Pearson, M. A.; Hofmann, F.; Anderson, K. C.; Kung, A. L. Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell. 2004, 4, 221-230.
14. Ryan, P. D.; Goss, P. E. The emerging role of the insulin-like growth factor pathway as a therapeutical target in cancer. The Oncologist. 2008, 13, 16-24.
15. Gerber, H. P.; McMurtrey, A.; Kowalski, J.; Yan, M.; Keyt, B. A.; Dixit, V.; Ferrara, N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/ Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 1998, 273, 30336-30343.
16. Korpelainen, E. L; Alitalo, K. Signaling angiogenesis and lym-phangiogenesis. Curr. Omn. Cell Biol. 1998, 10, 159-164.
17. Thiele, W.; Sleeman, J. P. Tumor-induced lymphangiogenesis: a target for cancer therapy. J. Biotechnol. 2006, 25, 224-241.
18. Kern, M.; Tjaden, Z.; Ngiewih, Y.; Puppel, N.; Will, F.; Dietrich, H; Pahlke, G; Marko, D. Inhibitors of the epidermal growth factor receptor in apple juice extract. Mol. Nutr. Food Res. 2005, 49, 317-328.
19. Marko, D.; Puppel, N.; Tjaden, Z.; Jakobs, S.; Pahlke, G The substitution pattern of anthocyanidins affects different cellular signalling cascades regulating cell proliferation. Mol. Nutr. Food Res. 2004, 48, 318-325.
20. Thomasset, C. S.; Berry, P. D.; Cai, H; West, K.; Marczylo, T. H; Marsden, D.; Brown, K.; Dennison, A.; Garcea, G.; Miller, A.; Hemingway, D.; Steward, W. P.; Gescher, A. J. Pilot study of oral anthocyanins for colorectal cancer chemoprevention Cancer Pre?. Res., in press.
21. Shumway, B. S.; Kresty, L. A.; Larsen, P. E.; Zwick, J. C.; Lu, B.; Fields, H. W.; Mumper, R. J.; Stoner, G. D.; Mallery, S. R. Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin. Cancer Res. 2008, 14, 2421-2430.
22. Kirkin, V.; Thiele, W.; Baumann, P.; Mazitschek, R.; Rohde, K.; Fellbrich, G; Weich, H; Waltenberger, J.; Giannis, A.; Sleeman, J. P. MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo. Int. J. Cancer 2004, 112, 986-993.
23. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
24. Fridrich, D.; Teller, N.; Esselen, M.; Pahlke, G; Marko, D. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Mol. Nutr. Food Res. 2008, 52, 815-822.
25. Kirkin, V.; Mazitschek, R.; Krishnan, J.; Steffen, A.; Waltenberger, J.; Pepper, M. S.; Giannis, A.; Sleeman, J. P. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur. J. Biochem. 2001, 268, 5530-5540.
26. Shimizu, M.; Deguchi, A.; Joe, A. K; McKoy, J. F.; Moriwaki, H; Weinstein, I. B. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J. EXD. Ther. Oncol. 2005, 5, 69-78.
27. Fridrich, D.; Kern, M.; Pahlke, G; Volz, N.; Will, E; Dietrich, H; Marko, D. Apple polyphenols diminish the phosphorylation of the epidermal growth factor receptor in HT29 colon carcinoma cells. Mol. Nutr. Food Res. 2007, 51, 594-601.
28. Shimizu, K; Kubo, H; Yamaguchi, K; Kawashima, K; Ueda, Y.; Matsuo, K; Awane, M.; Shimahara, Y.; Takabayashi, A.; Yamaoka, Y.; Satoh, S. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci. 2004, 95, 328-333.
29. Krishnan, J.; Kirkin, V.; Steffen, A.; Hegen, M.; Weih, D.; Tomarev, S.; Wilting, J; Sleeman, J. P. Differential in vivo and in vitro expression of VEGF-C and VEGF-D in tumors and its relationship to lymphatic metatasis in immunocompetent rats. Cancer Res. 2003, 63, 713-722.
30. He, Y.; Kozaki, K; Karpanen, T.; Koshikawa, K; Yla-Herttuala, S.; Takahashi, T.; Alitalo, K. Suppression of tumor lymphangiogenesis and lymph mode metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Nat. Cancer Inst. 2002, 94, 819-852.
31. Labrecque, L.; Lamy, S.; Chapus, A.; Mihoubi, S.; Durocher, Y.; Cass, B.; Bojanowski, M. W.; Gingras, D.; Béliveau, R. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005, 26, 821-826.
32. Lamy, S.; Gingras, D.; Béliveau, R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 2002, 62, 381-385.
33. Liu, M.; Li, X. Q.; Weber, C; Lee, C. Y.; Brown, J.; Liu, R. H. Antioxidant and antiproliferative activities of raspberries. J. Agric. Food Chem. 2002, 50, 2926-2930.
34. Zhao, C; Giusti, M. M.; Malik, M.; Moyer, M. P.; Magnuson, B. A. Effect of commercial anthocyanin-rich extracts on colonic cancer and nontumorigenic colon cell growth. J. Agric. Food Chem. 2004, 52, 6122-6128.
35. Fleschhut, J.; Kratzer, F.; Rechkemmer, G; Kulling, S. E. Stability and biotransformation of various dietary anthocyanins in vitro. Fur. J. Nutr. 2006, 45, 7-18.
36. Kern, M.; Fridrich, D.; Reichert, J.; Skrbek, S.; Nussher, A.; Hofem, S.; Vatter, S.; Pahlke, G; Rüfer, C; Marko, D. Limited stability in cell culture medium and hydrogen peroxide formation affect the growth inhibitory properties of delphinidin and its degradation product gallic acid. Mol. Nutr. Food Res. 2007, 51, 1163-1172.
37. Cooke, D.; Steward, W. P.; Gescher, A. J.; Marczylo, T. Anthocyans from fruits and vegetables - Does bright colour signal cancer chemopreventive activity. Fur. J. Cancer 2005, 41, 1931- 1940.
38. McGhie, T. K.; Walton, M. C. The bioavailabihty of anthocyanins: towards a better understanding. Mol. Nutr. Food Res. 2007, 51, 702-713.
39. Cooke, D.; Thomasset, S.; Boocock, D.; Schwarz, M.; Winterh-alter, P.; Steward, W. P.; Gescher, A. J.; Marczylo, T. Development of analyses by high-performance liquid chromatography and liquid chromatography/tandem mass spectrometry of bilberry (Vaccinium myrtilus) anthocyanins in human plasma and urine. J. Agric. Food Chem. 2006, 54, 7009-7013.